“Molecular Docking Study of Gingkgo Biloba Compounds As Potential Inhibitors of SARS-CoV-2”. SCRIPTA SCORE Scientific Medical Journal, vol. 4, no. 1, Sept. 2022, pp. 30-43, https://doi.org/10.32734/scripta.v4i1.8399.